UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (50651) 50651
Conference Proceeding (632) 632
Book Chapter (260) 260
Newspaper Article (162) 162
Book / eBook (46) 46
Magazine Article (36) 36
Newsletter (26) 26
Reference (9) 9
Government Document (7) 7
Trade Publication Article (5) 5
Publication (2) 2
Book Review (1) 1
Streaming Video (1) 1
Transcript (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
biological and medical sciences (48668) 48668
medical sciences (48594) 48594
nephrology. urinary tract diseases (48207) 48207
urinary tract. prostate gland (47405) 47405
humans (41517) 41517
science & technology (36793) 36793
life sciences & biomedicine (36616) 36616
male (34870) 34870
tumors of the urinary system (31892) 31892
urology & nephrology (20279) 20279
middle aged (20084) 20084
aged (19258) 19258
urinary system involvement in other diseases. miscellaneous (16157) 16157
female (14185) 14185
tumors (13794) 13794
adult (10980) 10980
abridged index medicus (10745) 10745
prostate cancer (10538) 10538
gynecology. andrology. obstetrics (10251) 10251
prostatic neoplasms - pathology (9266) 9266
male genital diseases (9098) 9098
oncology (8707) 8707
aged, 80 and over (7608) 7608
urology (5874) 5874
treatment outcome (4793) 4793
animals (4684) 4684
cancer (4356) 4356
risk factors (4239) 4239
prostate (4179) 4179
retrospective studies (4156) 4156
prognosis (4132) 4132
follow-up studies (4128) 4128
urinary bladder neoplasms - pathology (3768) 3768
prostate-specific antigen - blood (3723) 3723
neoplasm staging (3516) 3516
care and treatment (3495) 3495
prostatic neoplasms - surgery (3482) 3482
prospective studies (3356) 3356
prostatic neoplasms - genetics (3237) 3237
bladder cancer (2995) 2995
prostatic neoplasms - metabolism (2945) 2945
research (2934) 2934
prostatectomy (2877) 2877
time factors (2868) 2868
pharmacology. drug treatments (2786) 2786
surgery (2709) 2709
analysis (2701) 2701
adolescent (2666) 2666
prostatic neoplasms - blood (2642) 2642
immunohistochemistry (2616) 2616
child (2587) 2587
prostatic neoplasms - diagnosis (2567) 2567
prostatic neoplasms - drug therapy (2374) 2374
urinary incontinence (2369) 2369
prostate - pathology (2364) 2364
endocrinology & metabolism (2341) 2341
health aspects (2312) 2312
prostatic neoplasms (2308) 2308
bladder (2202) 2202
malformations of the urinary system (2156) 2156
cell line, tumor (2132) 2132
mice (2119) 2119
disease progression (2010) 2010
prostatic neoplasms - radiotherapy (1959) 1959
prostate-specific antigen (1952) 1952
prostatic neoplasms - therapy (1893) 1893
antineoplastic agents (1891) 1891
child, preschool (1848) 1848
sensitivity and specificity (1838) 1838
prostatic neoplasms - mortality (1798) 1798
quality of life (1779) 1779
biopsy (1776) 1776
diagnosis (1763) 1763
predictive value of tests (1738) 1738
pathology (1733) 1733
adenocarcinoma - pathology (1729) 1729
carcinoma, transitional cell - pathology (1683) 1683
cohort studies (1679) 1679
urodynamics (1621) 1621
case-control studies (1596) 1596
urinary bladder neoplasms - surgery (1560) 1560
surveys and questionnaires (1541) 1541
radiology, nuclear medicine & medical imaging (1537) 1537
tumor cells, cultured (1490) 1490
oncology, experimental (1441) 1441
infant (1437) 1437
neoplasm invasiveness (1436) 1436
urinary bladder neoplasms - genetics (1427) 1427
prostatic neoplasms - epidemiology (1426) 1426
investigative techniques, diagnostic techniques (1388) 1388
prostatectomy - methods (1385) 1385
infectious diseases (1367) 1367
incidence (1355) 1355
rats (1353) 1353
general aspects (1321) 1321
ultrasonography (1321) 1321
urinary bladder (1296) 1296
risk assessment (1266) 1266
multivariate analysis (1254) 1254
age factors (1248) 1248
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
St. Michael's Hospital - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Online Resources - Online (2) 2
Scarborough Hospital - General (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - Birchmount (1) 1
Toronto East General Hospital - Online (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (51811) 51811
French (28) 28
German (21) 21
Japanese (18) 18
Russian (12) 12
Portuguese (9) 9
Spanish (9) 9
Danish (3) 3
Croatian (2) 2
Turkish (2) 2
Dutch (1) 1
Norwegian (1) 1
Polish (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
European urology, ISSN 0302-2838, 2013, Volume 64, Issue 1, pp. 118 - 140
Urology | α-Adrenoreceptor antagonist | Desmopressin | Botulinum toxin injections | Transurethral resection of the prostate | Ethanol injections | 5α-Reductase inhibitor | Transurethral needle ablation | Prostate stent | Transurethral incision of the prostate | Muscarinic receptor antagonist | Open prostatectomy | Laser prostatectomy | Benign prostatic hyperplasia | Transurethral microwave therapy | Bipolar transurethral resection of the prostate | Lower urinary tract symptoms | Phosphodiesterase inhibitors | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Urinary system involvement in other diseases. Miscellaneous | Severity of Illness Index | Phosphodiesterase Inhibitors - therapeutic use | Risk Reduction Behavior | Humans | Prostatic Hyperplasia - therapy | Lower Urinary Tract Symptoms - physiopathology | Male | Transurethral Resection of Prostate - adverse effects | Treatment Outcome | 5-alpha Reductase Inhibitors - therapeutic use | Muscarinic Antagonists - therapeutic use | Lower Urinary Tract Symptoms - therapy | Transurethral Resection of Prostate - standards | Urology - standards | Urological Agents - adverse effects | Prostatic Hyperplasia - diagnosis | Adrenergic alpha-1 Receptor Antagonists - therapeutic use | Urinary Catheterization - standards | Lower Urinary Tract Symptoms - diagnosis | Prostatic Hyperplasia - physiopathology | Stents - standards | Watchful Waiting - standards | Urological Agents - therapeutic use | Practice guidelines (Medicine) | Medical colleges | Bipolar disorder | Desmopressin acetate | Ablation (Surgery) | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 13, pp. 1192 - 1202
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Enzyme Inhibitors - adverse effects | Prostatic Neoplasms - pathology | Prostatic Hyperplasia - pathology | Double-Blind Method | Erectile Dysfunction - chemically induced | Humans | Middle Aged | 5-alpha Reductase Inhibitors | Male | Risk | Treatment Outcome | Azasteroids - therapeutic use | Enzyme Inhibitors - therapeutic use | Prostate-Specific Antigen - blood | Azasteroids - adverse effects | Prostate - pathology | Prostatic Neoplasms - genetics | Biopsy | Protein Isoforms | Dutasteride | Aged | Prostatic Neoplasms - prevention & control | Prostatic Hyperplasia - drug therapy | Heart Failure - chemically induced | Usage | Diagnosis | Health aspects | Prostate cancer | Risk factors | Patient safety | Age | Men | Index Medicus | Abridged Index Medicus | Prostate-Specific Antigen | Erectile Dysfunction | Enzyme Inhibitors | Testosterone 5-alpha-Reductase | Prostatic Hyperplasia | Life Sciences | Prostatic Neoplasms | Azasteroids | Heart Failure | Prostate | Cancer | pathology | genetics | Urologi och njurmedicin | chemically induced | drug therapy | prevention & control | blood | adverse effects | Cancer and Oncology | Urology and Nephrology | therapeutic use | Cancer och onkologi | Medicin och hälsovetenskap
Journal Article
European urology, ISSN 0302-2838, 2012, Volume 63, Issue 3, pp. 521 - 527
Journal Article